More than 20 departments and over 500 researchers from the University are engaged in projects aimed at understanding and dealing with the Covid-19 coronavirus. Work on a wide range of activities is benefitting from £20m of government fundingread more...
Scientists from Oxford University have developed a rapid test for COVID-19 that is three times faster than previous techniques.
Life science teams at the Oxfordshire-based Diamond Light Sources synchrotron facility are ‘working around the clock’, carrying out measurements to help international efforts to tackle COVID-19.
Research started in Oxford University’s chemistry laboratories has evolved into a biophysical discovery platform that delivers high-resolution data to aid the discovery of therapeutics for patients suffering from immunological and genetic disorders
Much of the NHS’s digital effort focuses on how to improve clinical outcomes and internal processes, and to reduce the burgeoning costs of healthcare within its walls. Oxfordshire start-up Cognitant has looked beyond these parameters, and set its sights on improving the flow of information to patients.
The government’s recent decision to allow international students to stay in the UK for two years to find a job after graduation is “wonderful”, according to Professor Lionel Tarassenko, head […]
Data science company Genomics has announced Professor Gil McVean will join on a full-time basis as chief information officer.
Clinicians, suppliers and The Royal College of Radiologists continue to be concerned about the possible consequences of the UK's departure from the Euratom Treaty. In Oxford University Hospitals NHS Trust, more than 500,000 procedures each year involve ionising radiation. Uncertainty continues around the safeguarding controls and the continuity of supply of radioisotopes caused by the Brexit negotiations and, in particular, the prospect of a no-deal exit at the end of October.
Oxford biotech company e-therapeutics is offering its powerful network-biology-and AI-based drug discovery platform to help tackle the Covid-19 pandemic.
Researchers in Oxford and Zurich have used artificial intelligence (AI) and computer visualisation technology to detect changes in colon cancer cells that could be connected to the ‘expression’ of some smell-sensing genes.
Using its proprietary tech, a biotech company has discovered antibodies leading to the development of drug discovery programmes in kidney disease and cancer.
TheHill is a digital health innovation community, a cluster, network and incubator/accelerator programme working in Oxford with NHS Trusts, universities, digital developers, innovators and investors to catalyse commercial and impactful technological solutions in healthcare.
If you’ve ever wondered why the effects of a prescribed drug were stronger than the doctor promised, why you can’t reach the top shelf in a supermarket, or why you […]
POSTPONED Safety in numbers – next generation patient monitoring and data analysis in acute care – talk by Dr Keith Errey, CEO and co-founder of Isansys and strong advocate of digital and data-driven methods in healthcare. 12 to 1.30pm at Bio Escalator, 696 Roosevelt Drive, Oxford, OX3 7FZ. Details
Internet of Things Thames Valley April This regular gathering of the IoT community goes online for the first time with speakers from Jaguar Land Rover and Happiest Minds on connected cars, NVIDIA on autonomous objects, Computer Futures on women in tech, Thames Valley Berkshire on the connected city cluster and MIT Dynamic Technologies on carbon emissions reduction. From 7pm online. Click here to register.
POSTPONED Manufacturing Connect Event – Future Factories Connect, share and create opportunities with some of the region‘s brightest manufacturers. 10am to 1pm at Crowcon Detection Instruments Ltd, 172 Park Drive, Abingdon OX14 4SD Postponed until further notice, click here for details.